Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

256 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Alloreactive T Cells Display a Distinct Chemokine Profile in Response to Conditioning in Xenogeneic GVHD Models.
Kawasaki Y, Sato K, Nakano H, Hayakawa H, Izawa J, Takayama N, Mashima K, Oh I, Minakata D, Yamasaki R, Morita K, Ashizawa M, Yamamoto C, Hatano K, Fujiwara SI, Ohmine K, Muroi K, Ito R, Hayakawa M, Ohmori T, Kanda Y. Kawasaki Y, et al. Among authors: izawa j. Transplantation. 2019 Sep;103(9):1834-1843. doi: 10.1097/TP.0000000000002756. Transplantation. 2019. PMID: 31461746
Comparison of alemtuzumab, anti-thymocyte globulin, and post-transplant cyclophosphamide for graft-versus-host disease and graft-versus-leukemia in murine models.
Mashima K, Oh I, Fujiwara K, Izawa J, Takayama N, Nakano H, Kawasaki Y, Minakata D, Yamasaki R, Morita K, Ashizawa M, Yamamoto C, Hatano K, Sato K, Ohmine K, Fujiwara SI, Ohno N, Kanda Y. Mashima K, et al. Among authors: izawa j. PLoS One. 2021 Jan 11;16(1):e0245232. doi: 10.1371/journal.pone.0245232. eCollection 2021. PLoS One. 2021. PMID: 33428661 Free PMC article.
Dimethyl fumarate ameliorates graft-versus-host disease by inhibiting T-cell metabolism and immune responses through a reactive oxygen species-dependent mechanism.
Mashima K, Sato K, Ikeda T, Izawa J, Takayama N, Hayakawa H, Kawaguchi SI, Nakano H, Nagayama T, Umino K, Morita K, Tominaga K, Endo H, Kanda Y. Mashima K, et al. Among authors: izawa j. Br J Haematol. 2022 Jun;197(6):e78-e82. doi: 10.1111/bjh.18082. Epub 2022 Feb 15. Br J Haematol. 2022. PMID: 35170051 No abstract available.
Mesenchymal Stromal Cells Inhibit Aerobic Glycolysis in Activated T Cells by Negatively Regulating Hexokinase II Activity Through PD-1/PD-L1 Interaction.
Kawasaki Y, Sato K, Mashima K, Nakano H, Ikeda T, Umino K, Morita K, Izawa J, Takayama N, Hayakawa H, Tominaga K, Endo H, Kanda Y. Kawasaki Y, et al. Among authors: izawa j. Transplant Cell Ther. 2021 Mar;27(3):231.e1-231.e8. doi: 10.1016/j.jtct.2020.11.012. Epub 2020 Dec 14. Transplant Cell Ther. 2021. PMID: 35348117 Free article.
Benefit of Neoadjuvant Cisplatin-based Chemotherapy for Invasive Bladder Cancer Patients Treated with Radiation-based Therapy in a Real-world Setting: An Inverse Probability Treatment Weighted Analysis.
Kool R, Dragomir A, Kulkarni GS, Marcq G, Breau RH, Kim M, Busca I, Abdi H, Dawidek M, Uy M, Fervaha G, Cury FL, Alimohamed N, Izawa J, Jeldres C, Rendon R, Shayegan B, Siemens R, Black PC, Kassouf W. Kool R, et al. Among authors: izawa j. Eur Urol Oncol. 2024 Feb 6:S2588-9311(24)00040-3. doi: 10.1016/j.euo.2024.01.014. Online ahead of print. Eur Urol Oncol. 2024. PMID: 38326142
256 results